AILERON THERAPEUTICS INC — Form D
AILERON THERAPEUTICS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-06. The offering totals $40.0M, of which $30.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-01-06
- Form: D
- Accession: 0001420565-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $30.1M
- Remaining: $9.9M
- Investors: 11
- Date of first sale: 2016-12-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-277814
Issuer
- Name: AILERON THERAPEUTICS INC
- CIK: 0001420565
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 840 MEMORIAL DRIVE, CAMBRIDGE, MA, 02139
- Phone: 617-995-0900
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Brian M Gallagher, Jr. | Director | Cambridge, MA |
| Seth L Harrison | Director | — |
| Scott L Kapnick | Director | Cambridge, MA |
| John H McArthur | Director | Cambridge, MA |
| Armen H Shanafelt | Director | Cambridge, MA |
| Caleb H Winder | Director | Cambridge, MA |
| Joseph A Yanchik III | Director | Cambridge, MA |
| Manuel H Aivado | Executive Officer | Cambridge, MA |
| Joseph A Yanchik III | Executive Officer | Cambridge, MA |
| Seth Harrison | Director | Redwood City, CA |
| Alan H Musso | Director | Waltham, MA |
| Reinhard J Ambros | Director | Waltham, MA |
| Nolan H Sigal, M.D., Ph.D. | Director | Waltham, MA |
| William H Fairey | Director | Waltham, MA |
| Josef H von Rickenbach | Director | Waltham, MA |
| Manuel Alves-Aivado, M.D., Ph.D. | Director | Waltham, MA |
| Manuel Alves-Aivado, M.D., Ph.D. | Executive Officer | Waltham, MA |
| Brian L Windsor, Ph.D. | Executive Officer | Waltham, MA |
| Susan L Drexler | Executive Officer | Waltham, MA |
| Campbell Murray | Director | NOVATO, CA |
| Enrico Petrillo | Director | Boston, MA |
| Enrico H Petrillo | Director | Cambridge, MA |
| Michael Diem | Director | Conshocken, PA |
Other filings by this issuer (4)
More